AMBALAL SARABHAI ENTERPRISES LTD. Q4 FY26 Results

Summary

Ambalal Sarabhai Enterprises Limited concluded the financial year ended March 31, 2026, with a consolidated revenue from operations reaching ₹20,227.17 Lakhs, representing a 3.09% increase year-on-year. The company demonstrated strong profit growth, with profit after tax for FY26 rising significantly by 33.27% to ₹1,517.17 Lakhs. For the fourth quarter of FY26, revenue from operations was ₹650.73 Lakhs, while profit after tax jumped by 60.00% to ₹261.18 Lakhs. The Board also approved several key corporate actions, including director re-appointments and recommendations for inter-corporate loans to group entities.

Key Highlights

1. 1

   Ambalal Sarabhai Enterprises Limited reported a 3.09% year-on-year increase in revenue from operations, reaching ₹20,227.17 Lakhs for the financial year ended March 31, 2026.

2. 2

   The company's Profit after Tax (PAT) for FY26 grew significantly by 33.27% to ₹1,517.17 Lakhs, compared to ₹1,138.45 Lakhs in the previous fiscal year.

3. 3

   Profit before share of joint ventures, associate, and exceptional items surged by 68.93% year-on-year to ₹1,890.45 Lakhs for the full financial year 2026.

4. 4

   For the fourth quarter ended March 31, 2026, revenue from operations stood at ₹650.73 Lakhs, a 1.11% increase from ₹643.55 Lakhs in Q4 FY25.

5. 5

   Q4 FY26 witnessed a substantial 60.00% rise in Profit after Tax to ₹261.18 Lakhs, up from ₹163.25 Lakhs in the corresponding quarter of the prior year.

6. 6

   The Board recommended the re-appointment of Mr. Kartikeya V. Sarabhai as Executive Chairman, Ms. Chaula M. Shastri as Whole-time Director, and Mr. Mohal K. Sarabhai as Managing Director for periods of three years, all effective from 2026 or 2027.

7. 7

   The company recommended granting inter-corporate loans to Asence Pharma Private Limited, Synbiotics Limited, and Systronics India Limited.